Corrigendum to “Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo” [Eur. J. Pharm. Biopharm. 117 (2017

Corrigendum to "Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo" [Eur. J. Pharm. Biopharm. 117 (2017) 400-407]

Authors

Institutions

Publication Details

Journal
European Journal of Pharmaceutics and Biopharmaceutics
Published
2025-11-20
DOI
https://doi.org/10.1016/j.ejpb.2025.114926
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Corrigendum to “Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo” [Eur. J. Pharm. Biopharm. 117 (2017

Eneko Larrañeta, Adrien Kissenpfennig, Maelíosa McCrudden, Shauna Hegarty et al.
European Journal of Pharmaceutics and Biopharmaceutics
Advancements in Transdermal Drug Delivery
article

Corrigendum to “Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo” [Eur. J. Pharm. Biopharm. 117 (2017

Eneko Larrañeta, Adrien Kissenpfennig, Maelíosa McCrudden, Shauna Hegarty, Ryan F. Donnelly, Eva M. Vicente‐Pérez, Helen O. McCarthy
article en

Abstract

Corrigendum to "Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo" [Eur. J. Pharm. Biopharm. 117 (2017) 400-407]

European Journal of Pharmaceutics and BiopharmaceuticsVol. 218
Queen's University Belfast (GB), Royal Victoria Hospital (GB)
Openalex Percentile: Top 72%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.